Ellex builds on glaucoma market

Company News

by Rachael Jones

Ellex Medical Lasers (ASX:ELX) has seen a growing interest in their business after showcasing their products at the American Glaucoma Society’s annual meeting.

Headquartered in Adelaide Ellex is a global leader in medical devices for diagnosis and treatment of eye disease.
The total global glaucoma market is $US5 billion.

Ellex maintains its position as the only company in the world to offer both a glaucoma treatment laser and minimally invasive glaucoma surgery.

Shares in Ellex (ASX:ELX) last traded at $0.82.
 

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?